sb 239063 has been researched along with Cardiac Remodeling, Ventricular in 1 studies
SB 239063: structure in first source
SB-239063 : A member of the class of imidazoles carrying 4-hydroxycyclohexyl, 4-fluorophenyl and 2-methoxypyrimidin-4-yl substituents at positions 1, 4 and 5 respectively.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Despite a reduction of inflammation, treatment with the p38 inhibitor SB 239063 does not affect cardiac remodelling and cardiac function when treatment is started 7 days after myocardial infarction." | 3.74 | Role of p38 mitogen-activated protein kinase in cardiac remodelling. ( Angermann, CE; Bauersachs, J; Behr, T; Ertl, G; Fraccarollo, D; Frantz, S; Goldberg, E; Hu, K; Strotmann, J, 2007) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Frantz, S | 1 |
| Behr, T | 1 |
| Hu, K | 1 |
| Fraccarollo, D | 1 |
| Strotmann, J | 1 |
| Goldberg, E | 1 |
| Ertl, G | 1 |
| Angermann, CE | 1 |
| Bauersachs, J | 1 |
1 other study available for sb 239063 and Cardiac Remodeling, Ventricular
| Article | Year |
|---|---|
Role of p38 mitogen-activated protein kinase in cardiac remodelling.
Topics: Animals; Imidazoles; Inflammation; Male; Myocardial Infarction; p38 Mitogen-Activated Protein Kinase | 2007 |